• About us
• Contact

Advertisement

Organisation › Details

Ysios Capital (Group)

Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage, highly innovative life science companies bringing life-changing treatments to patients, with a focus on indications with high unmet need. Our diverse international team in San Sebastián and Barcelona is driven by science, with the ambition to transform capital into medical breakthroughs. Ysios Capital was founded in 2008 and has over $450 million in assets under management through its three funds. *

 

Name: Ysios Capital Partners

Web/URL: www.ysioscapital.com


Contact:

Address: travessera de gràcia, 11 floor 8th 08021 Barcelona, Catalonia, Spain
Telephone: +34-93-5173545
General contact: [email protected]


Profile:

Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage human healthcare and life science companies with a special focus on pharmaceuticals, diagnostics and medical devices.

Founded in 2008, Ysios Capital has € 125 million in assets under management distributed over two funds. The second fund has a target size of € 100 million and will remain open to new investors until December 2015.


Industry: Venture capital, life sciences

Products/Services: Investment

Established: 2008

Employees: 11


The organisation submitted the information to [LSE] on 18 August 2015.

	Start	2008-01-01 established
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Jean-Mairet, Joël (Ysios Capital 201206)
	Region	Barcelona
	Country	Spain (España)
	Street	11 Travessera de Gràcia 8th Floor
	City	08021 Barcelona
	Tel	+34-93-517-3545
		Address record changed: 2021-04-28
Basic data	Employees	B: 11 to 50
	Currency	EUR
	Annual sales	450,000,000 (assets, managed (2022) 2022-03-04)
		* Document for »About Section«: Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona.
		Record changed: 2024-03-23

Advertisement

More documents for Ysios Capital (Group)

• [1] Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren....
• [2] Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA....
• [3] Ysios Capital. (1/19/23). "Press Release: Ysios Capital Strengthens Its Team with Internal Promotions and a New Venture Partner". San Sebastián & Barcelona....
• [4] SparingVision SAS. (9/14/22). "Press Release: SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases"....
• [5] Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona....
• [6] NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam....
• [7] SOM Biotech S.L.. (6/23/21). "Press Release: SOM Biotech Appoints Marc Casellas as Chief Financial Officer". Barcelona....
• [8] Cytoki Pharma ApS. (5/5/21). "Press Release: Cytoki Pharma Raises $45 Million Series A Financing". Copenhagen....
• [9] Synendos Therapeutics AG. (4/20/21). "Press Release: Synendos Therapeutics Expands Series A to CHF 24 million with New Investment". Basel....
• [10] VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.